<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5</volume><submitter>Buyukyoruk M</submitter><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><journal>Cell discovery</journal><pagination>54</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6868142</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Type I-F CRISPR-Cas provides protection from DNA, but not RNA phages.</pubmed_title><pmcid>PMC6868142</pmcid><funding_grant_id>R01 GM110270</funding_grant_id><funding_grant_id>R01GM110270</funding_grant_id><pubmed_authors>Buyukyoruk M</pubmed_authors><pubmed_authors>Wiedenheft B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Type I-F CRISPR-Cas provides protection from DNA, but not RNA phages.</name><description/><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2025-04-04T14:02:06.439Z</modification><creation>2025-04-04T14:02:06.439Z</creation></dates><accession>S-EPMC6868142</accession><cross_references><pubmed>31798958</pubmed><doi>10.1038/s41421-019-0123-9</doi></cross_references></HashMap>